首页> 外文期刊>Transfusion medicine reviews >Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?
【24h】

Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

机译:对乙酰氨基酚和苯海拉明对过敏性和发热性非溶血性输血反应的处方:预防还是不良做法?

获取原文
获取原文并翻译 | 示例
           

摘要

Febrile nonhemolytic and allergic reactions are the most common transfusion reactions, but usually do not cause significant morbidity. In an attempt to prevent these reactions, US physicians prescribe acetaminophen or diphenhydramine premedication before more than 50% of blood component transfusions. Acetaminophen and diphenhydramine are effective therapies for fever and allergy, respectively, so their use in transfusion has some biologic rationale. However, these medications also have potential toxicity, particularly in ill patients, and in the studies performed to date, they have failed to prevent transfusion reactions. Whether the benefits of routine prophylaxis with acetaminophen and diphenhydramine outweigh their risks and cost requires reexamination, particularly in light of the low reaction rates reported at many institutions even when premedication is not prescribed.
机译:发热的非溶血和过敏反应是最常见的输血反应,但通常不会引起明显的发病。为了防止这些反应,美国医师在输注超过50%的血液之前开出了对乙酰氨基酚或苯海拉明的处方药。对乙酰氨基酚和苯海拉明分别是发烧和过敏的有效疗法,因此在输血中使用它们具有一定的生物学原理。但是,这些药物也具有潜在的毒性,特别是在生病的患者中,并且在迄今为止进行的研究中,它们未能预防输血反应。对乙酰氨基酚和苯海拉明进行常规预防的益处是否超过其风险和成本,需要重新审查,特别是考虑到许多机构报告的低反应率,即使没有处方药也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号